Advocates on Steps of Congress 2013
Please leave this field empty
Scleroderma Foundation
Homepage | Forward to a Friend | Make a Donation
eletter banner.jpg
eLetter #644 | January 29, 2016  

New Promising Treatment for Scleroderma Related Interstitial Lung Disease (ILD)

Scleroderma-related-interstitial-lung-disease-can-be-treatedInterstitial lung disease is common in systemic sclerosis and is the leading cause of death.  However, there is a new promising treatment for patients suffering from ILD.  If discovered early on, prognosis can be positive for patients.

Click here for more details >>

For Kids Only!

138005991.jpgYour childhood and teen years are a prime time to learn habits that will help you keep your bones, joints, muscles and skin healthy for years to come.  The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH) is a great resource for updates and features.

Click here to explore their website >>

Making Progress in Protecting Consumers from Unsafe Supplements

fda logo.gifIn a previous eLetter, we provided information about how to talk to your doctor about consuming dietary and herbal supplements.  The FDA is doing their part to keep you safe.  Here is a look at the important steps they have recently taken to protect your health.

Click here for more from the FDA >>

Coping with Caregiving

download.jpgTaking care of a loved one with a serious medical condition is certainly a labor of love.  Did you know that approximately 43 million adults living in the United States provide unpaid care for someone with a serious health condition?  Here is some information to help you also take care of yourself. 

Click here for more >>

Donate Button
Quick Links
Advocacy
Contact Us
Become a Member
About Scleroderma
Calendar of Events
Online Chat
Store
Home
facebook_32.png
twitter_32.png
Youtube_32x32.png Actelion 2016 sponsor
2016 Bayer Logo


 

 

Disclaimer: The Scleroderma Foundation in no way endorses any drugs, treatments, clinical trials, or studies reported in the eLetter. Information is provided to keep the readers informed. Because the manifestations and severity of scleroderma vary among individuals, personalized medical management is essential. Therefore, it is strongly recommended that all drugs and treatments be discussed with the reader’s physician(s) for proper evaluation and treatment.

Powered by Blackbaud  Unsubscribe | Visit our web site | Contact Us | Donate
300 Rosewood Drive, Suite 105, Danvers, MA 01923 tel: 800-722-HOPE (4673)
© 2017 All rights reserved.